Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests
Detection Principle
ImmunoAssay-Antibody
Target
Euroimmun: S1; Wantai: spike;
Testing Method Category
Other Immuno assay
Testing Method
Euroimmun SARS-CoV-2 IgA and IgG ELISAs (Euroimmun), Wantai SARS-CoV-2 IgM and total antibody ELISAs (Beijing Wantai Biological Pharmacy), Wantai SARS-CoV-2 Ab Rapid Test (Beijing Wantai), 2019-nCoV IgG/IgM Rapid Test (Hangzhou AllTest Biotech)
Testing Method - Additional Info
Comparison of performance among 2 ELISA: Euroimmun SARS-CoV-2 IgA and IgG ELISAs (Euroimmun), Wantai SARS-CoV-2 IgM and total antibody ELISAs (Beijing Wantai Biological Pharmacy); and 2 rapid tests the Wantai SARS-CoV-2 Ab Rapid Test (Beijing Wantai), and the 2019-nCoV IgG/IgM Rapid Test (Hangzhou AllTest Biotech)
Reported Performance
Sensitivity: the Euroimmun IgA and IgG ELISAs tested positive in 9 (30%) and 1 (3.3%) of the 30 individuals in group tested at < 5 d from symptoms, in 21 (84%) and 10 (40%) of the 25 at d 6-10, in all 22 patients (100%) at d>21. The Wantai IgM and total antibody ELISAs tested positive in 8 (26.7%) and 11 (36.7%) of the 30 individuals tested at <5d from symptoms. Both tests provided positive results in 23 of 25 patients (92%) at d 6-10 and in all 22 (100%) at d>21. The Wantai rapid test tested positive in 6 of 30 individuals (20%) tested at <5d from symptoms, in 20 of 25 (80%) at d 6-10, and in all 22 (100%) at d>21. The 2019-nCoV IgG/IgM Rapid Test tested 6 of the 30 (20%) patients positive IgM at < 5 d from symptoms and 4/30 (13.3%) a positive IgG band. At d 6-10 5 (20%) displayed weakly positive IgM and 12 (48%) clearly positive IgG bands. At d >21, 10 (45.5%) showed a weakly positive IgM band, and all 22 (100%) displayed a clearly positive IgG band. Specificity: Euroimmune IgA 83%; Euroimmune IgG 98%; Wantai IgM and total Ab: 97%; Wantai rapid test: 98%; 2019-nCoV IgG/IgM Rapid Test IgM 99%; IgG 100% .
Sample Size
77 positive. 100 negative
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements